Comments
Loading...

MedBright AI Investments Analyst Ratings

MBAIFOTCQB
Logo brought to you by Benzinga Data
$0.0444
-0.01-19.19%
At close: -

MedBright AI Investments Analyst Ratings and Price Targets | OTC:MBAIF | Benzinga

MedBright AI Investments Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for MedBright AI Investments Corp from these most-recent analyst ratings.

Analyst Ratings for MedBright AI Investments

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for MedBright AI Investments (MBAIF) stock?

A

There is no price target for MedBright AI Investments

Q

What is the most recent analyst rating for MedBright AI Investments (MBAIF)?

A

There is no analyst for MedBright AI Investments

Q

When was the last upgrade for MedBright AI Investments (MBAIF)?

A

There is no last upgrade for MedBright AI Investments

Q

When was the last downgrade for MedBright AI Investments (MBAIF)?

A

There is no last downgrade for MedBright AI Investments.

Q

When is the next analyst rating going to be posted or updated for MedBright AI Investments (MBAIF)?

A

There is no next analyst rating for MedBright AI Investments.

Q

Is the Analyst Rating MedBright AI Investments (MBAIF) correct?

A

There is no next analyst rating for MedBright AI Investments.

Browse analyst ratings and price targets on all stocks.